Milestone Pharmaceuticals Inc.
MIST· Nasdaq
Released Nov 12, 2024, before the open
10-Q filed Nov 12, 2024, 43 days after period end · 0001558370-24-015147
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$9.44M | -$15.08M | -$14.56M | -$14.23M |
| EPS Diluted | -$0.14 | -$0.35 | -$0.34 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR